Cite
Upadacitinib in a patient with concurrent refractory axial Spondyloarthritis and inflammatory bowel disease: A case report.
MLA
Li, Xingjian, et al. “Upadacitinib in a Patient with Concurrent Refractory Axial Spondyloarthritis and Inflammatory Bowel Disease: A Case Report.” International Journal of Rheumatic Diseases, vol. 27, no. 6, June 2024, pp. 1–4. EBSCOhost, https://doi.org/10.1111/1756-185X.15222.
APA
Li, X., Pan, X., Zheng, S., Yi, G., Zhong, X., Zhang, Y., Huang, Z., & Li, T. (2024). Upadacitinib in a patient with concurrent refractory axial Spondyloarthritis and inflammatory bowel disease: A case report. International Journal of Rheumatic Diseases, 27(6), 1–4. https://doi.org/10.1111/1756-185X.15222
Chicago
Li, Xingjian, Xia Pan, Shaoling Zheng, Guanqun Yi, Xiaoyan Zhong, Yuexi Zhang, Zhengping Huang, and Tianwang Li. 2024. “Upadacitinib in a Patient with Concurrent Refractory Axial Spondyloarthritis and Inflammatory Bowel Disease: A Case Report.” International Journal of Rheumatic Diseases 27 (6): 1–4. doi:10.1111/1756-185X.15222.